Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = Qutenza®

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
9 pages, 431 KB  
Review
Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
by Luca Gregorio Giaccari, Caterina Aurilio, Francesco Coppolino, Maria Caterina Pace, Maria Beatrice Passsavanti, Vincenzo Pota and Pasquale Sansone
J. Pers. Med. 2021, 11(10), 960; https://doi.org/10.3390/jpm11100960 - 27 Sep 2021
Cited by 24 | Viewed by 7023
Abstract
(1) Background: Surgery is a frequent cause of persistent pain, defined chronic post-surgical pain (CPSP). The capsaicin 8% patch (Qutenza®) is approved for the treatment of postherpetic neuralgia (PHN) and for diabetic peripheral neuropathy (DPN) of the feet. We propose [...] Read more.
(1) Background: Surgery is a frequent cause of persistent pain, defined chronic post-surgical pain (CPSP). The capsaicin 8% patch (Qutenza®) is approved for the treatment of postherpetic neuralgia (PHN) and for diabetic peripheral neuropathy (DPN) of the feet. We propose a review of the literature on use of the capsaicin 8% patch to treat neuropathic pain associated with surgery; (2) Methods: We identified the articles by searching electronic databases using a combination of such terms as “capsaicin 8% patch”, “Qutenza®”, and “chronic postsurgical pain”; (3) Results: We identified 14 selected studies reporting on a total of 632 CPSP cases treated with capsaicin 8% patch. Treatment with the capsaicin 8% patch significantly reduced the average pain intensity. Only 5 studies reported adverse events (AEs) after the patch application. The most common AEs were erythema, burning sensation and pain; (4) Conclusions: Our review indicate that capsaicin 8% patch treatment for CPSP is effective, safe and well tolerated, but randomized controlled trials on efficacy, safety and tolerability should be conducted. Full article
(This article belongs to the Special Issue Advances in the Therapeutics of Neurological Diseases)
Show Figures

Figure 1

Back to TopTop